Cardiome -- CRME Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cardiome -- CRME

CRME 2.330

-2.1%

May 16 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: dr.praveen who wrote (3)	7/27/2006 11:14:34 AM
From: dr.praveen	of 285

AZN has dropped development of AZD 7009 for atrial fibrillation Navid Malik at Collins Stewart said the decision to end development of an intravenous form of experimental drug AZD 7009 for atrial fibrallation also knocked sentiment. <My previous post has a little info on SE of AZD 7009. Waiting for the 600mg oral dose results in September from Cardiome> yahoo.reuters.com. Regards, Praveen

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next